A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MVD / multivessel disease

[Related PubMed/MEDLINE]
Total Number of Papers: 179
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MVD  (>> Co-occurring Abbreviation)
Long Form:   multivessel disease
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A score for decision making during percutaneous coronary intervention in acute myocardial infarction patients with multivessel disease. AMI, CONVERSE, COREA-AMI, MACEs, MV, PCI
2019 Angiogram based fractional flow reserve in patients with dual/triple vessel coronary artery disease. wbFFR
2019 Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease. PCI, SSII, SUA, UPLMD
2019 Complete and incomplete revascularization in non-ST segment myocardial infarction with multivessel disease: long-term outcomes of first- and second-generation drug-eluting stents. CR, DES, IR, MACE, NSTEMI
2019 Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials. CI, CR, ICR, IRA, MACE, PCI, RCTs, RR, RRs, SCR, STEMI
2019 Computed tomographic coronary angiography in risk stratification prior to non-cardiac surgery: a systematic review and meta-analysis. CAC, CAD, MACE
2019 Extended dual antiplatelet therapy for Asian patients with acute coronary syndrome: expert recommendations. ACS, BVS, CKD, DAPT, DM, MI, PAD
2019 Fractional flow reserve-guided complete revascularization versus culprit-only revascularization in acute ST-segment elevation myocardial infarction and multi-vessel disease patients: a meta-analysis and systematic review. COR, CR, FFR, IRA, MACE, RCTs, STEMI, STMEI
2019 Immediate multivessel intervention versus culprit-vessel intervention only in patients with ST-elevation myocardial infarction and multivessel coronary disease: data from the prospective KAMIR-NIH registry. CI, CVI-O, HR, MI, MVI, STEMI
10  2019 Impact of the angiographic burden on the incidence of out-of-hospital ventricular fibrillation in patients with acute myocardial infarction. AMI, CI, CTO, LCA, OR, VF
11  2019 Major adverse cardiovascular events while awaiting staged non-culprit percutaneous coronary intervention after ST-segment elevation myocardial infarction. CR, MACEs, PCI, SR, STEMI
12  2019 Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease. CI, HR, MACE, PCI, STEMI
13  2019 [Predictive value of neutrophil to lymphocyte ratio on long-term outcomes of acute myocardial infarction patients with multivessel disease]. AMI, eGFR, hs-CRP, IABP, MACCE, NLR, PCI
14  2018 An Exploratory Study of Washout Rate Analysis for Thallium-201 Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging Using Cadmium Zinc Telluride Detectors. conventional SPECT, CZT SPECT, MPI, SPECT, WOR
15  2018 Chronic obstructive pulmonary disease affects the angiographic presentation and outcomes of patients with coronary artery disease treated with percutaneous coronary interventions. CAD, COPD, LMCA, NSTEMI, PCI, STEMI
16  2018 Clinical outcomes of complete revascularization using either angiography-guided or fractional flow reserve-guided drug-eluting stent implantation in non-culprit vessels in ST elevation myocardial infarction patients: insights from a study based on a systematic review and meta-analysis. CR, OR, PCI, STEMI
17  2018 Complete revascularization for patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: a meta-analysis of randomized trials. CENTRAL, CR, IRA, PCI, RCTs, RRs, STEMI
18  2018 Complete Versus Culprit-Only Lesion Intervention in Patients With AcuteCoronary Syndromes. BCIS, NSTEMI, PCI
19  2018 Complete Versus Culprit-Only Revascularization for ST-Segment Elevation Myocardial Infarction and Multivessel Disease in the 2nd Generation Drug-Eluting Stent Era: Data from the INTERSTELLAR Registry. CI, CR, CV, DES, HR, MACE, PCI, STEMI
20  2018 Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction. LAD, LCX, PCI, RCA, STEMI
21  2018 Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study). ACS, AMI, MACE, MI
22  2018 Hospitalization Length after Myocardial Infarction: Risk-Assessment-Based Time of Hospital Discharge vs. Real Life Practice. LOS, LVEF, MI
23  2018 Hypertension Is an Independent Predictor of Multivessel Coronary Artery Disease in Young Adults with Acute Coronary Syndrome. ACS, BMI, CAD, CAG, MACE, SVD
24  2018 Impact of chronic total occlusion in a non-infarct-related coronary artery on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction. CMR, CTO, MACE, non-IRA, STEMI, SVD
25  2018 Impact of Routine Invasive Physiology atTime of Angiography in Patients WithMultivessel Coronary Artery Diseaseon Reclassification of Revascularization Strategy: Results From the DEFINE REAL Study. FFR, iFR, IQR
26  2018 Incomplete revascularization: what the surgeon needs to know. CABG, CR, IR, PCI
27  2018 Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials. BMS, CABG, CrI, CVA, LMD, MACE, MI, NG-DES, OG-DES, OR, PCI
28  2018 Long-term outcomes and predictors of morbi-mortality according to age in stemi patients with multivessel disease: Impact of an incomplete revascularization. CR, IR, MACE, STEMI
29  2018 Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease. CI, PCI, RCT, RR, STEMI
30  2018 Microvascular obstruction in non-infarct related coronary arteries is an independent predictor of major adverse cardiovascular events in patients with ST segment-elevation myocardial infarction. IRA, MACE, MVO
31  2018 Network Meta-analysis of percutaneous intervention-based revascularization strategies for ST-elevation myocardial infarction and concomitant multi-vessel disease. CIN, IRA, NMA, PCI, RCTs, STEMI, SUCRA
32  2018 Relationship of 82Rb PET territorial myocardial asynchrony to arterial stenosis. ROC AUC
33  2018 Revascularization for Left Main and Multivessel Coronary Artery Disease: Current Status and Future Prospects after the EXCEL and NOBLE Trials. LMD, NOBLE
34  2018 Revascularization strategies in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis. AMI, CI, COR, CS, IMVR, RR, RR, RR, RR, RR
35  2018 Revascularization strategies in STEMI with multivessel disease: when and how. IRA, PCI, STEMI
36  2018 The prognostic impact of revascularization strategy in acute myocardial infarction and cardiogenic shock: Insights from the British Columbia Cardiac Registry. AMI, CS, CVI, PCI
37  2018 Transradial versus transfemoral intervention in non-ST-segment elevation acute coronary syndrome patients undergoing percutaneous coronary intervention: the Korean transradial intervention registry of 1 285 patients. CD, CKD, MACE, MI, NSTE-ACS, RR, TFI, TRI
38  2018 Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function. LVEF, MACCE, PCI
39  2017 Assessing MICRO-vascular resistances via IMR to predict outcome in STEMI patients with multivessel disease undergoing primary PCI (AMICRO): Rationale and design of a prospective multicenter clinical trial. FFR, IRA, LV, PPCI
40  2017 Association of red cell distribution width with noninfarct-related artery-chronic total occlusion in acute myocardial infarction patients. AMI, CTO, non-IRA, OR, RDW, STEMI
41  2017 Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial. IDR, MI, OR, PCI, ST, SVD
42  2017 Chronic total occlusion in a non-infarct-related artery is closely associated with increased five-year mortality in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the CREDO-Kyoto AMI registry). CI, CTO, HR, IRA, STEMI
43  2017 Collateral filling efficiency of comorbid chronic total occlusion segment on short-term mortality in ST-elevation myocardial infarction. CTO, IRA, PCI, STEMI
44  2017 Comparison of coronary artery bypass grafting and drug-eluting stents in patients with chronic kidney disease and multivessel disease: A meta-analysis. CABG, CKD, ESRD, MACCE, PCI-DES
45  2017 Comparison of the presence of fragmented QRS complexes in the inferior versus the anterior leads for predicting coronary artery disease severity. CAD, ECG, fQRS, SXscore
46  2017 Correlations between High Platelet Reactivity, Extent of Coronary Artery Disease, and Periprocedural Myonecrosis in Patients with Acute Coronary Syndrome. ACS, HPR, PCI, PRU
47  2017 Impact of the presence of chronically occluded coronary artery on long-term prognosis of patients with acute ST-segment elevation myocardial infarction. CTO, PCI, STEMI
48  2017 Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials. CABG, MI, PCI
49  2017 Inter-ethnic marriages and severity of coronary artery disease: A multicenter study of Arabian Gulf States. CAD
50  2017 Low QRS Voltage on Presenting Electrocardiogram Predicts Multi-vessel Disease in Anterior ST-segment Elevation Myocardial Infarction. CABG, STEMI
51  2017 Non-infarct related artery revascularization in ST-segment elevation myocardial infarction patients with multivessel disease. CV, PCI, STEMI
52  2017 Optimal Timing of Percutaneous Coronary Intervention for Nonculprit Vessel in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease. CI, MACEs, MI, OR, PCI, STEMI
53  2017 Polygamy and Risk of Coronary Artery Disease in Men Undergoing Angiography: An Observational Study. CABG, CAD, LMD
54  2017 Socioeconomic Factors and Severity of Coronary Artery Disease in Patients Undergoing Coronary Angiography: A Multicentre Study of Arabian Gulf States. CAD, CAG, LMD, PCI
55  2017 The optimal strategy of percutaneous coronary intervention for ST-elevation myocardial infarction patients with multivessel disease: an updated meta-analysis of 9 randomized controlled trials. CMV-PCI, MACEs, PCI, S-PCI, STEMI
56  2016 A multi-artery Fractional Flow Reserve (FFR) approach for handling coronary stenosis-stenosis interaction in the multi-vessel disease (MVD) arena. FFR, SVD
57  2016 Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease. CABG, DES, DM, PCI
58  2016 Complete vs Culprit-Only Percutaneous Coronary Intervention in STEMI With Multivessel Disease: A Meta-analysis and Trial Sequential Analysis of Randomized Trials. CI, CR, MI, OR, PCI, STEMI
59  2016 Culprit Vessel-Only vs. Staged Multivessel Percutaneous Coronary Intervention Strategies in Patients With Multivessel Coronary Artery Disease Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. PCI, STEMI
60  2016 Culprit-only versus staged complete revascularization for patients with ST-segment elevation myocardial infarction and Multivessel disease: a retrospective cohort study. STEMI
61  2016 Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI. CABG, DCath, HT, PCI
62  2016 Impact of complete revascularization in patients with ST-elevation myocardial infarction: analysis of a 10-year all-comers prospective registry. CR, MACE, PCI, STEMI
63  2016 Impact of the origin of the collateral feeding donor artery on short-term mortality in ST-elevation myocardial infarction with comorbid chronic total occlusion. CTO, IRA, STEMI, SVD
64  2016 Impact of the Residual SYNTAX Score on Outcomes of Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease. CAD, CVA, MACCE, MI, PPCI, rSS, STEMI
65  2016 Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data. IRA, MV-PCI, NIS, STEMI, SVPCI
66  2016 Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with percutaneous coronary interventions. BA, BMS, CABG, CI, DES, HR, LITA, PCI, SV
67  2016 Regarding article, "A multi-artery fractional flow reserve (FFR) approach for handling coronary stenosis-stenosis interaction in the multi-vessel disease (MVD) arena". FFR
68  2016 REPLY: A multi-artery fractional flow reserve (FFR) approach for handling coronary stenosis-stenosis interaction in the multi-vessel disease (MVD) arena. FFR
69  2016 Serum IgE levels are associated with coronary artery disease severity. CAD, IgE
70  2016 Staged versus "one-time" multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome. MI, NSTE-ACS, PCI
71  2016 Timing of Staged Percutaneous Coronary Intervention for a Non-Culprit Lesion in Patients With Anterior Wall ST Segment Elevation Myocardial Infarction With Multiple Vessel Disease. PCI, STEMI
72  2015 Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies. CABG, LM, MI, OCTs, PCI-DES, RCTs
73  2015 Culprit or multivessel revascularisation in ST-elevation myocardial infarction with cardiogenic shock. PCI, STEMI
74  2015 Fractional Flow Reserve in Acute Myocardial Infarction: A Guide for Non-Culprit Lesions? FFR, STEMI
75  2015 Impact of hypertension on postreperfusion left ventricular recovery in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease. ASBP, LV, MMI, PPCI, STEMI
76  2015 Physiology-guided myocardial revascularisation in complex multivessel coronary artery disease: beyond the 2014 ESC/EACTS guidelines on myocardial revascularisation. CABG, PCI
77  2015 Prognosis of STEMI Patients with Multi-Vessel Disease Undergoing Culprit-Only PCI without Significant Residual Ischemia on Non-Invasive Stress Testing. MACE, PPCI, STEMI, SVD
78  2015 Serum Bone Morphogenic Protein-4 Contributes to Discriminating Coronary Artery Disease Severity. AUC, BMP-4, CAD, CI, SVD
79  2015 Very high coronary artery calcium score with normal myocardial perfusion SPECT imaging is associated with a moderate incidence of severe coronary artery disease. CAC, CAD, LM, MI, MPI
80  2015 [Evaluation of different revascularization strategies for patients with acute myocardial infarction with lesions of multiple coronary arteries after primary percutaneous coronary intervention and its economic evaluation]. AMI, MACE, non-IRA, PCI, RCT
81  2014 A meta-analysis of adjusted risk estimates for survival from observational studies of complete versus incomplete revascularization in patients with multivessel disease undergoing coronary artery bypass grafting. CABG
82  2014 Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry. BMS, MACCE, MVPCI, PCI, STEMI
83  2014 Association of Helicobacter pylori infection with coronary artery disease: is Helicobacter pylori a risk factor? CAD, HP, SVD
84  2014 Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials. CABG, CI, LAD, LM, PCI, RR, RR, RR
85  2014 Culprit vessel only versus multivessel percutaneous coronary intervention in patients presenting with ST-segment elevation myocardial infarction and multivessel disease. CNKI, MV-PCI, OR, PCI, STEMI
86  2014 Evaluation of the effect of concurrent chronic total occlusion and successful staged revascularization on long-term mortality in patients with ST-elevation myocardial infarction. CI, CTO, HR, IRA, MACE, PCI, STEMI, SVD
87  2014 Impact of completeness of revascularization by coronary intervention on exercise capacity early after acute ST-elevation myocardial infarction. CI, CR, IR, MI, PCI, STEMI, SVD
88  2014 Long-term incidence and prognostic factors of the progression of new coronary lesions in Japanese coronary artery disease patients after percutaneous coronary intervention. CAD, HDL, PCI
89  2014 Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry. CI, HR, PPCI, STEMI
90  2014 Long-term outcomes of complete versus incomplete revascularization for patients with multivessel coronary artery disease and left ventricular systolic dysfunction in drug-eluting stent era. CI, CR, HR, IR, LVEF, MACCE
91  2014 Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials. CV-PCI, MACE, MVPCI, PCI, RCTs, RR, S-PCI, STEMI
92  2014 Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated systematic review and meta-analysis. CABG, CVE, DES, MACCE, MI, PCI, RCTs
93  2014 [Value of admission electrocardiogram for predicting multivessel disease in acute anterior and anterior-inferior myocardial infarction]. ECG
94  2013 Comparison of Three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial). HORIZONS-AMI, LV, LVEFs, PCI
95  2013 Complete versus culprit-only revascularization during primary percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis. CI, CR, OR, PCI, RCTs, STEMI
96  2013 Effect of multivessel coronary artery disease with or without a concomitant chronic total occlusion on 1-year survival in patients treated with rescue angioplasty. CI, CTO, HR, PCI, SVD
97  2013 How Should We Treat Multi-Vessel Disease in STEMI Patients? STEMI
98  2013 Incidence and clinical impact of concurrent chronic total occlusion according to gender in ST-elevation myocardial infarction. CTO, STEMI, SVD
99  2013 Management of multivessel coronary artery disease. GDMT
100  2013 Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice. CABG, PCI